Overview
Karim Aouam practices in Monastir, Tunisia. Mr. Aouam is rated as an Experienced expert by MediFind in the treatment of Anaphylaxis. His top areas of expertise are DRESS Syndrome, COVID-19, Pustules, Thiopurine S-Methyltransferase Deficiency, and Kidney Transplant.
His clinical research consists of co-authoring 91 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Anaphylaxis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- DRESS SyndromeMr. Aouam isElite. Learn about DRESS Syndrome.
- Advanced
- COVID-19Mr. Aouam isAdvanced. Learn about COVID-19.
- Eosinophilia-Myalgia SyndromeMr. Aouam isAdvanced. Learn about Eosinophilia-Myalgia Syndrome.
- HivesMr. Aouam isAdvanced. Learn about Hives.
- PustulesMr. Aouam isAdvanced. Learn about Pustules.
- Thiopurine S-Methyltransferase Deficiency
- Experienced
- Acute Febrile Neutrophilic DermatosisMr. Aouam isExperienced. Learn about Acute Febrile Neutrophilic Dermatosis.
- Acute PancreatitisMr. Aouam isExperienced. Learn about Acute Pancreatitis.
- AnaphylaxisMr. Aouam isExperienced. Learn about Anaphylaxis.
- BullaeMr. Aouam isExperienced. Learn about Bullae.
- CholecystitisMr. Aouam isExperienced. Learn about Cholecystitis.
- Chronic Myelogenous Leukemia (CML)Mr. Aouam isExperienced. Learn about Chronic Myelogenous Leukemia (CML).